The 2025 Workshop Program is under development.
Program is subject to change.
Please see the 2024 program below.
FRIDAY , JULY 26
Workshop Pretest available, to be completed by 1 p.m. on Sunday, July 28
SUNDAY, JULY 28
Registration
1:30 pm-5:30 pm
Faculty Meeting
4:30 pm-5:15 pm
Welcome/Overview
5:30 pm-5:45 pm
Manuel Hidalgo, Weill Cornell Medicine, New York Presbyterian Hospital, New York, New York
Wendy B. London, Dana-Farber Cancer Institute and Boston Children’s Hospital, Boston, Massachusetts
Julie M. Vose, University of Nebraska Medical Center, Omaha, Nebraska
Opening Keynote Lecture
Session Chair: Manuel Hidalgo, Weill Cornell Medicine, New York Presbyterian Hospital, New York, New York
5:45 pm-6:30 pm
- Career Development Opportunities: The Government Can Help
Oliver Bogler, National Cancer Institute, Rockville, Maryland
Dinner/Protocol Development Group Session 1
6:30 pm-8:30 pm
MONDAY, JULY 29
Breakfast
7:00 am-8:00 am
Lecture Session 1
8:00 am-9:45 am
- Answering Important Questions: From Hypothesis to Analysis
Wendy B. London, Dana-Farber Cancer Institute and Boston Children’s Hospital, Boston, Massachusetts - Phase I Trial Questions
Manuel Hidalgo, Weill Cornell Medicine, New York Presbyterian Hospital, New York, New York - Phase I Trial Designs
Shing Lee, Columbia University, New York, New York
Questions / Panel Discussion
Break
9:45 am-10:00 am
Lecture Session 2
10:00 am-12:00 pm
- Phase II Trial Questions/Objectives
Maha Hussain, Northwestern University Feinberg School of Medicine, Chicago, Ilinois - Phase II Trial Designs
Sean Devlin, Memorial Sloan Kettering Cancer Center, New York, New York - Drug Combination Trials
George A. Fisher, Jr., Stanford Cancer Institute, Stanford, California - Multimodality Trials
Adam P. Dicker, Thomas Jefferson University, Philadelphia, Pennsylvania
Questions / Panel Discussion
Lunch
12:00 pm-1:30 pm
Protocol Development Group Session 2
1:30 pm-4:00 pm
Independent Study Time
4:00 pm-7:00 pm
Personalized Mentoring Session 1 (Biostatisticians and Patient Advocates; prescheduled appointments)
4:15 pm-6:30 pm
ASSIGNMENT DUE: PROTOCOL TEMPLATE
7:00 pm
Dinner
7:00 pm-9:00 pm
TUESDAY, JULY 30
Breakfast
7 am-8 am
Lecture Session 3
8:00 am-9:40 am
- Feasibility and Reproducibility in Biomarker Studies
Kurt A. Schalper, Yale University, New Haven, Connecticut - Incorporation of Biological Correlative Studies into Early Clinical Trials
Jordi Rodon Ahnert, The University of Texas MD Anderson Cancer Center, Houston, Texas - Statistical Aspects of Correlative Studies
James R. Anderson, University of Nebraska Medical Center, Omaha, Nebraska
Questions / Panel Discussion
Break
9:40 am-10:00 am
Lecture Session 4
10:00 am-11:40 am
- Imaging in the Era of Targeted Therapy and Immunotherapy
Ammar Chaudhry, AstraZeneca, Yorba Linda, California - Special Considerations in the Design of Immunotherapy Studies
Amir A. Jazaeri, The University of Texas MD Anderson Cancer Center, Houston, Texas - Barriers to Accrual and How to Overcome Them
Ruth O’Regan, University of Rochester, Rochester, New York
Questions / Panel Discussion
Lunch
11:40 am-12:45 pm
Protocol Development Group Session 3
12:45 pm-3:45 pm
Independent Study Time
3:45 pm-7:00 pm
Personalized Mentoring Session 2: Protocol Related Questions
3:45 pm-6:00 pm
Room locations noted on signup sheets
(Signup sheets will be available during the morning break.)
Dinner (Grab and Go)
5:00 pm-7:00 pm
ASSIGNMENT DUE: STATISTICAL DESIGN
7:00 pm
WEDNESDAY, JULY 31
Breakfast
7:00 am-8:00 am
Small Group Discussion Sessions 1-3
8:00 am-9:00 am
- Elements of Artificial Intelligence
Carole Baas, NCI Physical Sciences in Oncology Network, Southlake, Texas
Ammar Chaudhry, AstraZeneca, Yorba Linda, California
Neal J. Meropol, Flatiron Health, New York, New York
John Rice, University of Michigan, Ann Arbor, Michigan - Symptom Management, Patient Reported Outcomes, and Quality of Life
Vijaya R. Bhatt, University of Nebraska Medical Center, Omaha, Nebraska
Jill Feldman, EGFR Resisters, Evanston, Illinois
Sujata Patil, Cleveland Clinic, Cleveland, Ohio - Phase III Trials
Maura N. Dickler, Genentech, South San Francisco, California
Josh Mailman, NorCal CarciNET Community, Oakland, California
Lindsay Renfro, University of Southern California, Los Angeles, California
Break
9:00 am-9:15 am
Small Group Discussion Sessions 4-6
9:15 am-10:15 am
- Navigating the National Clinical Trials Network
Vijaya R. Bhatt, University of Nebraska Medical Center, Omaha, Nebraska
Colin Weekes, Massachusetts General Hospital, Boston, Massachusetts - Laboratory Correlates, ctDNA, and Liquid Biopsy
Emily V. Dressler, Wake Forest University School of Medicine, Winston-Salem, North Carolina
Ruth O’Regan, University of Rochester, Rochester, New York
Kurt A. Schalper, Yale University, New Haven, Connecticut
Break / Group Photo
10:15 am-10:45 am
Small Group Discussion Sessions 7-9
10:45 am-11:45 am
- Defining, Identifying, and Knowing Your Trial’s Clinical Endpoints
John Byrd, University of Cincinnati College of Medicine, Cincinnati, Ohio
Chen Hu, Johns Hopkins University, Baltimore, Maryland
Sanford Jeames, PCORI/Huston-Tillotson University, Austin, Texas - Understanding the Regulatory Process
Jordi Rodon Ahnert, The University of Texas MD Anderson Cancer Center, Houston, Texas
James R. Anderson, University of Nebraska Medical Center, Omaha, Nebraska
Neal J. Meropol, Flatiron Health, New York, New York
Franklin Smith, Medpace, Cincinnati, Ohio - Large-Scale Genomic Analysis: Bench to Bedside
Manju George, Colontown, Crowdsville, Maryland
David B. Solit, Memorial Sloan Kettering Cancer Center, New York, New York
Lunch
11:45 am-12:30 pm
Protocol Development Group Session 4
12:30 pm-2:30 pm
Independent Study Time/Dinner on Own
2:30 pm-7:00 pm
Personalized Mentoring Session 3: Protocol Related Questions
3:45 pm-6:00 pm
Room locations noted on signup sheets
(Signup sheets will be available during the morning break.)
ASSIGNMENT DUE: PROTOCOL DRAFTS
7:00 pm
THURSDAY, AUGUST 1
Breakfast
7:00 am-8:00 am
Lecture Session 5
8:00 am-9:40 am
- You’re in Charge: Investigator Responsibilities
John P. Leonard, Weill Cornell Medicine, New York, New York - How to Pay for Your Trial
Richard D. Carvajal, Northwell Health Cancer Institute, New York, New York - Everything You Need to Know About Clinical Trial Ethics and Informed Consent
Diana T. Chingos, DTC Consulting, Los Angeles, California
Laura C. Michaelis, Medical College of Wisconsin, Milwaukee, Wisconsin
Questions / Panel Discussion
Break
9:40 am-9:55 am
Lecture Session 6
9:55 am-11:35 am
- Data Collection: It’s All In the Data
Mark Krailo, Children’s Oncology Group, Los Angeles, California - Inclusivity in Clinical Trials
Everett E. Dodson, Georgetown Lombardi Comprehensive Cancer Center (Retired), Washington DC
Colin Weekes, Massachusetts General Hospital, Boston, Massachusetts - Community Engagement
Sanford Jeames, PCORI/Huston-Tillotson University, Austin, Texas
Questions / Panel Discussion
Break
11:35 am-11:45 am
Keynote Lecture
11:45 am-12:35 pm
- Patricia M. LoRusso, Yale Cancer Center, New Haven, Connecticut
Lunch
12:35 pm-1:30 pm
Protocol Development Group Session 5
1:30 pm-3:00 pm
Independent Study Time/Dinner on Own
3:00 pm-7:00 pm
Personalized Mentoring Session 4: Informed Consent/Protocol Related Questions, and Career Guidance
3:15pm-5:30 pm
Room locations noted on signup sheets
(Signup sheets will be available during the morning breaks.)
Optional Networking Session: Women in Hematology/Oncology
5:30 pm-6:30 pm
ASSIGNMENT DUE: INFORMED CONSENT DOCUMENTS
7:00 pm
FRIDAY, AUGUST 2
Breakfast
7:00 am-8:30 am
Faculty Meeting (Faculty Only)
7:30 am-8:30 am
Optional Career Sessions
(Exact topics to be determined based on accepted applicant interests, topics shown below are examples from past Workshops)
8:30 am-9:30 am
- Collaborating and Networking
Maura N. Dickler, Genentech, South San Francisco, California
Andrew M. Lowy, University of California, San Diego, California
Neal J. Meropol, Flatiron Health, New York, New York - Work-Life Balance
Jeff Bogart, State University of New York, Syracuse, New York
Tari King, Dana-Farber Cancer Institute/Brigham and Women’s Cancer, Boston, Massachusetts
Franklin O. Smith, Medpace, Cincinnati, Ohio - Career Transition and Advancement Tips
David B. Solit, Memorial Sloan Kettering Cancer Center, New York, New York
Julie M. Vose, University of Nebraska Medical Center, Omaha, Nebraska
Break
9:30 am-9:45 am
Lecture Session 7
9:45 am-11:15 am
- Successful Grantsmanship
Alex A. Adjei, Cleveland Clinic, Cleveland, Ohio - Reporting and Presenting Results
Tari King, Dana-Farber Cancer Institute/Brigham and Women’s Cancer Center, Boston, Massachusetts
Shing Lee, Columbia University, New York, New York
Mary W. Redman, Fred Hutchinson Cancer Center, Seattle, Washington
Questions / Panel Discussion
Break
11:15 am-11:30 pm
Protocol Development Group Session 6
11:30 am-1:00 pm
Lunch (Boxed)
1:00 pm-2:00 pm
Administration of Post-test
1:00 pm-4:00 pm
Independent Study Time
1:00 pm-7:00 pm
ASSIGNMENT DUE: FINAL PROTOCOLS, INFORMED CONSENT FORMS, and ALL WORKSHOP EVALUATIONS
7:00 pm
Closing Reception / Banquet / Dance
7:00 pm-11:00 pm
SATURDAY, AUGUST 3
Departure (on own)